☰

Shaji Theodore, Ph.D. - Publications

Affiliations: 
2006 University of Kentucky, Lexington, KY 
Area:
Toxicology, Neuroscience Biology, Virology Biology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Theodore S, Maragos W. 6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease. Immunopharmacology and Immunotoxicology. 37: 393-9. PMID 26211726 DOI: 10.3109/08923973.2015.1070172  0.619
2012 Theodore S, Cass WA, Dwoskin LP, Maragos WF. HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse (New York, N.Y.). 66: 755-7. PMID 22517264 DOI: 10.1002/Syn.21564  0.641
2010 Cao S, Theodore S, Standaert DG. Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease. Molecular Neurodegeneration. 5: 42. PMID 20977765 DOI: 10.1186/1750-1326-5-42  0.609
2008 Theodore S, Cao S, McLean PJ, Standaert DG. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. Journal of Neuropathology and Experimental Neurology. 67: 1149-58. PMID 19018246 DOI: 10.1097/Nen.0B013E31818E5E99  0.628
2007 Theodore S, Cass WA, Nath A, Maragos WF. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Current Hiv Research. 5: 301-13. PMID 17504172 DOI: 10.2174/157016207780636515  0.63
2006 Theodore S, Stolberg S, Cass WA, Maragos WF. Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Annals of the New York Academy of Sciences. 1074: 178-90. PMID 17105916 DOI: 10.1196/Annals.1369.018  0.702
2006 Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Neurobiology of Disease. 23: 663-8. PMID 16828290 DOI: 10.1016/J.Nbd.2006.05.005  0.656
2006 Theodore S, Cass WA, Maragos WF. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Experimental Neurology. 199: 490-8. PMID 16510141 DOI: 10.1016/J.Expneurol.2006.01.009  0.692
2006 Theodore S, Cass WA, Maragos WF. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience. 137: 925-35. PMID 16338084 DOI: 10.1016/J.Neuroscience.2005.10.056  0.664
Show low-probability matches.